Breakthroughs in liver cancer treatment
We sit down with health care executive Eugene Chan to explore the rising rates of liver cancer worldwide and the potential game-changer in its treatment: monoclonal antibodies. Join us as we delve into the factors contributing to liver cancer’s prevalence, the impact of vaccination, and the promising future of mAbs as a more precise and effective treatment approach. Discover the latest research on bi-specific antibodies and the ongoing efforts to improve outcomes for patients battling hepatocellular carcinoma (HCC).
Eugene Chan is a health care executive.
He discusses the KevinMD article, “Diversified treatments are needed to fight the increasing threat of liver cancer.”
Our presenting sponsor is Nuance, a Microsoft company.
Together, Microsoft and Nuance are leveraging their rich digital technology and advanced AI capabilities to tackle some of health care’s biggest challenges. AI-driven technology promises to revolutionize patient and provider experiences with clinical documentation that writes itself.
The Nuance Dragon Ambient eXperience, or DAX for short, is a voice-enabled solution that automatically captures patient encounters securely and accurately at the point of care. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows.
Physicians who use DAX have reported a 50 percent decrease in documentation time and a 70 percent reduction in feelings of burnout, and 85 percent of patients say their physician is more personable and conversational.
Discover AI-powered clinical documentation that writes itself. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo.
VISIT SPONSOR → https://nuance.com/daxinaction
SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast
RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended
GET CME FOR THIS EPISODE → https://earnc.me/FT8GkE
Powered by CMEfy.
